Myriad Genetics (MYGN) Net Cash Flow Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -298.36% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -7,202.13% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 665.15% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 117.44% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -58.16% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 722.22% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -320.00% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -1,722.22% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -273.33% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -129.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.09% |
| Dec 31, 2025 | -228.57% |
| Sep 30, 2025 | 1,294.12% |
| Jun 30, 2025 | -1,178.57% |
| Mar 31, 2025 | 68.12% |
| Dec 31, 2024 | -94.93% |
| Sep 30, 2024 | 118.82% |
| Jun 30, 2024 | -102.84% |
| Mar 31, 2024 | -885.71% |
| Dec 31, 2023 | 222.67% |
| Sep 30, 2023 | -642.00% |
| Jun 30, 2023 | 183.28% |
| Mar 31, 2023 | 96.22% |
| Dec 31, 2022 | -23.29% |
| Sep 30, 2022 | -97.18% |
| Jun 30, 2022 | -98.66% |
| Mar 31, 2022 | -393.97% |
| Dec 31, 2021 | 23.64% |
| Sep 30, 2021 | 484.38% |
| Jun 30, 2021 | -136.56% |